JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gillart, T.
Right arrow Articles by Schoeffler, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gillart, T.
Right arrow Articles by Schoeffler, P.
Anesth Analg 1999;89:1192
© 1999 International Anesthesia Research Society


REGIONAL ANESTHESIA AND PAIN MANAGEMENT

Lidocaine Plus Ropivacaine Versus Lidocaine Plus Bupivacaine for Peribulbar Anesthesia by Single Medial Injection

Thierry Gillart, MD*, Philippe Barrau, MD*, Jean E. Bazin, MD*, Ghislaine Roche, MD*, Frederic Chiambaretta, MD{dagger}, and Pierre Schoeffler, MD*

Departments of *Anesthesiology and {dagger}Ophthalmology, Centre Hospitalier Universitaire, Clermont-Ferrand, France

Address correspondence and reprint requests to T. Gillart, MD, Département d’Anesthésie-Réanimation, Centre Hospitalier Universitaire, 63003 Clermont-Ferrand, France.

This study was designed to compare the effects of ropivacaine and bupivacaine, each combined with lidocaine, during peribulbar anesthesia by single medial injection for cataract surgery. One hundred patients were included and randomly divided into two groups of 50, given a mixture of 50% bupivacaine (0.5%) and 50% lidocaine (2%) or 50% ropivacaine (1%) and 50% lidocaine (2%), and 25 U hyaluronidase per mL with each combination. After the first injection, patients given ropivacaine exhibited significantly better akinesia than those given bupivacaine, and significantly fewer were reinjected (19/50 vs 31/50). Among the patients reinjected, peroperative akinesia and analgesia proved satisfactory in both groups. We observed three cases of diplopia caused by retraction of the internal rectus muscle and two cases of moderate ptosis after superonasal reinjection. Hemodynamic profiles were similar in the two groups, and no major side effects were noted during the observation. One percent ropivacaine may be a more appropriate agent than 0.5% bupivacaine for peribulbar anesthesia by single medial injection.

Implications: One percent ropivacaine may be a more appropriate agent than 0.5% bupivacaine for peribulbar anesthesia by single medial injection. Combined with lidocaine, it provides better akinesia and similar analgesia.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
D. K. Woodward, A. T. S. Leung, M. W. I. Tse, R. W. K. Law, D. S. C. Lam, and W. D. Ngan Kee
Peribulbar anaesthesia with 1% ropivacaine and hyaluronidase 300 IU ml-1: comparison with 0.5%bupivacaine/2% lidocaine and hyaluronidase 50 IU ml-1
Br. J. Anaesth., October 1, 2000; 85(4): 618 - 620.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 1999 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1999 by the International Anesthesia Research Society.